ProCE Banner Activity

HBV Infection: When to Treat vs When to Monitor?

Clinical Thought
Would you treat or monitor a patient with low HBV DNA levels and high ALT? Here’s my take.

Released: February 21, 2018

Expiration: February 20, 2019

No longer available for credit.

Share

Faculty

Tram T. Tran

Tram T. Tran, MD

Medical Director of Liver Transplant
Comprehensive Transplant Center
Cedars Sinai Medical Center
Associate Professor of Medicine
Division of Gastroenterology
Geffen UCLA School of Medicine
Los Angeles, California

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

Gilead

Faculty Disclosure

Primary Author

Tram T. Tran, MD

Medical Director of Liver Transplant
Comprehensive Transplant Center
Cedars Sinai Medical Center
Associate Professor of Medicine
Division of Gastroenterology
Geffen UCLA School of Medicine
Los Angeles, California

Tram T. Tran, MD, has disclosed that she has received consulting fees, fees for non-CME/CE services, and funds for research support from Bristol-Myers Squibb and Gilead Sciences.